search button
Open Access

Novel ELISA for serodiagnosis of nasopharyngeal carcinoma based on a B cell epitope of Epstein‑Barr virus latent membrane protein 2

  • Authors:
    • Yiqi Cai
    • Yiling Song
    • Danwei Cen
    • Chanqiong Zhang
    • Shanshan Mao
    • Xiaoxian Ye
    • Yirong Xiong
    • Pengfei Jiang
    • Jun Chen
    • Xiangyang Xue
    • Lifang Zhang
    • Guanbao Zhu

  • View Affiliations

  • Published online on: July 25, 2018     https://doi.org/10.3892/ol.2018.9216
  • Pages: 4372-4378

  • Copyright: © Cai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Epstein‑Barr virus (EBV) is widespread and is associated with nasopharyngeal carcinoma (NPC). Serological detection of EBV is commonly used for screening, diagnosis and epidemiological surveys of NPC. In the present study, a novel B cell multi‑epitope peptide fusion protein (EBV‑LMP2‑3B), which is composed of three B cell linear epitopes (RIEDPPFNSLL, TLNLT and KSLSSTEFIPN) of EBV latent membrane protein 2 (LMP2), was expressed in a prokaryotic expression system and purified using Ni2+‑nitrilotriacetate‑Sepharose. The immunogenicity and binding specificity of EBV‑LMP2‑3B were evaluated on the basis of antibody responses in immunized BALB/c mice, western blotting and indirect immunofluorescence assay. Evaluation of EBV‑LMP2‑3B as a serological diagnostic reagent was performed using an indirect ELISA in 198 patients with NPC and 102 healthy adults. These results revealed that EBV‑LMP2‑3B was able to eliminate the high‑titer serum antibody response in BALB/c mice. Western blot analysis and indirect immunofluorescence assay confirmed that the mouse immune sera recognized the native LMP2. Compared with healthy adults, patients with NPC demonstrated significantly greater reactivity to EBV‑LMP2‑3B (P<0.05). Furthermore, it was possible to effectively detect specific IgG in sera from patients with NPC, with a sensitivity of 91.91% and specificity of 93.14%, representing an improvement over the traditional viral capsid antigen‑IgA‑based detection method with 59.59% sensitivity and 75.49% specificity. In conclusion, the EBV‑LMP2‑3B protein may be used as a serological diagnostic reagent to screen for and diagnose NPC.
View Figures
View References

Related Articles

Journal Cover

October-2018
Volume 16 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.9
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 6.3
  • CiteScore Rank: Q2: #119/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.725
  • SCImago Journal Rank (SJR): 0.639
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Cai Y, Song Y, Cen D, Zhang C, Mao S, Ye X, Xiong Y, Jiang P, Chen J, Xue X, Xue X, et al: Novel ELISA for serodiagnosis of nasopharyngeal carcinoma based on a B cell epitope of Epstein‑Barr virus latent membrane protein 2. Oncol Lett 16: 4372-4378, 2018
APA
Cai, Y., Song, Y., Cen, D., Zhang, C., Mao, S., Ye, X. ... Zhu, G. (2018). Novel ELISA for serodiagnosis of nasopharyngeal carcinoma based on a B cell epitope of Epstein‑Barr virus latent membrane protein 2. Oncology Letters, 16, 4372-4378. https://doi.org/10.3892/ol.2018.9216
MLA
Cai, Y., Song, Y., Cen, D., Zhang, C., Mao, S., Ye, X., Xiong, Y., Jiang, P., Chen, J., Xue, X., Zhang, L., Zhu, G."Novel ELISA for serodiagnosis of nasopharyngeal carcinoma based on a B cell epitope of Epstein‑Barr virus latent membrane protein 2". Oncology Letters 16.4 (2018): 4372-4378.
Chicago
Cai, Y., Song, Y., Cen, D., Zhang, C., Mao, S., Ye, X., Xiong, Y., Jiang, P., Chen, J., Xue, X., Zhang, L., Zhu, G."Novel ELISA for serodiagnosis of nasopharyngeal carcinoma based on a B cell epitope of Epstein‑Barr virus latent membrane protein 2". Oncology Letters 16, no. 4 (2018): 4372-4378. https://doi.org/10.3892/ol.2018.9216